您的位置: 首页 > 2024年5月 第55卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

减重手术对炎症因子影响的研究进展

Research progress on the impact of bariatric surgery on inflammatory factors

来源期刊: 广州医药 | 463-471 发布时间:2024-06-28 收稿时间:2025/11/17 15:49:12 阅读量:27
作者:
关键词:
减重手术炎症因子肥胖脂肪组织巨噬细胞
bariatric surgeryinflammatory factorsobesityadipose tissue macrophages
DOI:
10.3969/j.issn.1000-8535.2024.05.003
收稿时间:
2024-01-03 
修订日期:
 
接收日期:
 
引用总数:
0  
肥胖是一种以慢性低度炎症为特征的进展性疾病,与多种代谢性疾病的发生、发展密切相关。脂肪组织作为一种内分泌和免疫器官,可分泌多种生物活性物质及炎症因子,参与肥胖患者体内的代谢过程。减重手术是治疗病态性肥胖及相关代谢性疾病的有效方法之一,能够调节机体内的炎症反应、有效改善代谢状态。但减重手术对于炎症因子的作用如何,目前国内外的文献证据仍有争议。本文将系统阐述肥胖与代谢性炎症的关系以及减重手术对炎症因子的影响,旨在为肥胖代谢外科的诊疗过程提供参考。
Obesity is a progressive disease characterized by chronic low-grade inflammation,which is closely related to the occurrence and development of a variety of metabolic diseases.As an endocrine and immune organ,adipose tissue can secrete a variety of bioactive substances and inflammatory factors,which participate in the metabolic process of obese patients.Bariatric surgery is one of the effective methods for the treatment of morbid obesity and related metabolic diseases,which can regulate the inflammatory response in the machine and effectively improve the metabolic state.However,the effect of bariatric surgery on inflammatory factors is still controversial at home and abroad.This article will systematically explain the relationship between obesity and metabolic inflammation and the effect of bariatric surgery on inflammatory factors,aiming to provide a reference for the diagnosis and treatment process of bariatric surgery.
1、 SUBRAMANIAM R,ALIAKBARIAN H,BHUTTA H Y,et al.Sleeve gastrectomy and roux-en-Y gastric bypass attenuate pro-inflammatory small intestinal cytokine signatures[J].Obes Surg,2019(29):3824-3832. SUBRAMANIAM R,ALIAKBARIAN H,BHUTTA H Y,et al.Sleeve gastrectomy and roux-en-Y gastric bypass attenuate pro-inflammatory small intestinal cytokine signatures[J].Obes Surg,2019(29):3824-3832.
2、 SCHERNTHANER G-H,KOPP H-P,KRIWANEK S,et al.Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity[J].Obes Surg,2006,16(6):709-715. SCHERNTHANER G-H,KOPP H-P,KRIWANEK S,et al.Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity[J].Obes Surg,2006,16(6):709-715.
3、 SHARMA B R,KANNEGANTI T D.NLRP3 inflammasome in cancer and metabolic diseases[J].Nat Immunol,2021,22(5):550-559. SHARMA B R,KANNEGANTI T D.NLRP3 inflammasome in cancer and metabolic diseases[J].Nat Immunol,2021,22(5):550-559.
4、 ZHUANG H,HAN J,CHENG L,et al.A positive causal influence of IL-18 levels on the risk of T2DM:A Mendelian randomization study[J].Front Genet,2019(10):295. ZHUANG H,HAN J,CHENG L,et al.A positive causal influence of IL-18 levels on the risk of T2DM:A Mendelian randomization study[J].Front Genet,2019(10):295.
5、 NETEA M G,JOOSTEN L A,LEWIS E,et al.Deficiency of interleukin-18 in mice leads to hyperphagia,obesity and insulin resistance[J].Nat Med,2006,12(6):650-656. NETEA M G,JOOSTEN L A,LEWIS E,et al.Deficiency of interleukin-18 in mice leads to hyperphagia,obesity and insulin resistance[J].Nat Med,2006,12(6):650-656.
6、 ALBONI S,CERVIA D,SUGAMA S,et al.Interleukin 18 in the CNS[J].J Neuroinflammation,2010(7):9. ALBONI S,CERVIA D,SUGAMA S,et al.Interleukin 18 in the CNS[J].J Neuroinflammation,2010(7):9.
7、 KIM C S,PARK H S,KAWADA T,et al.Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters[J].Int J Obes,2006,30(9):1347-1355. KIM C S,PARK H S,KAWADA T,et al.Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters[J].Int J Obes,2006,30(9):1347-1355.
8、 HARAKEH S,KALAMEGAM G,PUSHPARAJ P N,et al.Chemokines and their association with body mass index among healthy Saudis[J].Saudi J Biol Sci,2020,27(1):6-11. HARAKEH S,KALAMEGAM G,PUSHPARAJ P N,et al.Chemokines and their association with body mass index among healthy Saudis[J].Saudi J Biol Sci,2020,27(1):6-11.
9、 SACHAN A,SINGH A,SHUKLA S,et al.An immediate post op and follow up assessment of circulating adipo-cytokines after bariatric surgery in morbid obesity[J].Metabol Open,2022(13):100147. SACHAN A,SINGH A,SHUKLA S,et al.An immediate post op and follow up assessment of circulating adipo-cytokines after bariatric surgery in morbid obesity[J].Metabol Open,2022(13):100147.
10、 ASKARPOUR M,KHANI D,SHEIKHI A,et al.Effect of bariatric surgery on serum inflammatory factors of obese patients:A systematic review and meta-analysis[J].Obes Surg,2019(29):2631-2647. ASKARPOUR M,KHANI D,SHEIKHI A,et al.Effect of bariatric surgery on serum inflammatory factors of obese patients:A systematic review and meta-analysis[J].Obes Surg,2019(29):2631-2647.
11、 JAMIALAHMADI T,ABBASIFARD M,REINER ?,et al.The effect of bariatric surgery on circulating levels of monocyte chemoattractant protein-1:A systematic review and meta-analysis[J].J Clin Med,2022,11(23):7021. JAMIALAHMADI T,ABBASIFARD M,REINER ?,et al.The effect of bariatric surgery on circulating levels of monocyte chemoattractant protein-1:A systematic review and meta-analysis[J].J Clin Med,2022,11(23):7021.
12、 THOMSEN S B,RATHCKE C N,J?RGENSEN N B,et al.Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects[J].J Obes,2013(2013):361781. THOMSEN S B,RATHCKE C N,J?RGENSEN N B,et al.Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects[J].J Obes,2013(2013):361781.
13、 CARMONA-MAURICI J,CUELLO E,RICART-JANé D,et al.Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity[J].Surg Obes Relat Dis,2020,16(12):1961-1970. CARMONA-MAURICI J,CUELLO E,RICART-JANé D,et al.Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity[J].Surg Obes Relat Dis,2020,16(12):1961-1970.
14、 ZOU Y,ZHOU C,XU H,et al.Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression[J].Life Sci,2020(241):117141. ZOU Y,ZHOU C,XU H,et al.Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression[J].Life Sci,2020(241):117141.
15、 BIANCONI V,SAHEBKAR A,ATKIN S L,et al.The regulation and importance of monocyte chemoattractant protein-1[J].Curr Opin Hematol,2018,25(1):44-51. BIANCONI V,SAHEBKAR A,ATKIN S L,et al.The regulation and importance of monocyte chemoattractant protein-1[J].Curr Opin Hematol,2018,25(1):44-51.
16、 HUANG J,CHEN Y,WANG X,et al.Change in adipokines and gastrointestinal hormones after bariatric surgery:A meta-analysis[J].Obes Surg,2023,33(3):789-806. HUANG J,CHEN Y,WANG X,et al.Change in adipokines and gastrointestinal hormones after bariatric surgery:A meta-analysis[J].Obes Surg,2023,33(3):789-806.
17、 FELIPE L A,BACHI A L,OLIVEIRA M C,et al.Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome:Randomized controlled clinical trial[J].Diabetol Metab Syndr,2023,15(1):19. FELIPE L A,BACHI A L,OLIVEIRA M C,et al.Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome:Randomized controlled clinical trial[J].Diabetol Metab Syndr,2023,15(1):19.
18、 EZQUERRO S,MOCHA F,FRüHBECK G,et al.Ghrelin reduces TNF-α-induced human hepatocyte apoptosis,autophagy,and pyroptosis:Role in obesity-associated NAFLD[J].J Clin Endocrinol Metab,2019,104(1):21-37. EZQUERRO S,MOCHA F,FRüHBECK G,et al.Ghrelin reduces TNF-α-induced human hepatocyte apoptosis,autophagy,and pyroptosis:Role in obesity-associated NAFLD[J].J Clin Endocrinol Metab,2019,104(1):21-37.
19、 OLSON A L.Regulation of GLUT4 and insulin-dependent glucose flux[J].ISRN Mol Biol,2012(2012):856987. OLSON A L.Regulation of GLUT4 and insulin-dependent glucose flux[J].ISRN Mol Biol,2012(2012):856987.
20、 EGUCHI A,WREE A,FELDSTEIN A E.Biomarkers of liver cell death[J].J Hepatol,2014,60(5):1063-1074. EGUCHI A,WREE A,FELDSTEIN A E.Biomarkers of liver cell death[J].J Hepatol,2014,60(5):1063-1074.
21、 AKASH M S H,REHMAN K,LIAQAT A.Tumor necrosis factor-alpha:Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J].J Cell Biochem,2018,119(1):105-110. AKASH M S H,REHMAN K,LIAQAT A.Tumor necrosis factor-alpha:Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J].J Cell Biochem,2018,119(1):105-110.
22、 MACHADO C R,BRAUN A M,CEOLIN J,et al.Variation of modulation and expression of biomarkers associated with inflammation in bariatric surgery patients:A systematic review and meta-analysis[J].Surgery,2023,174(5):1114-1144. MACHADO C R,BRAUN A M,CEOLIN J,et al.Variation of modulation and expression of biomarkers associated with inflammation in bariatric surgery patients:A systematic review and meta-analysis[J].Surgery,2023,174(5):1114-1144.
23、 ANTONIOLI L,MORICONI D,MASI S,et al.Differential impact of weight loss and glycemic control on inflammasome signaling[J].Obesity,2020,28(3):609-615. ANTONIOLI L,MORICONI D,MASI S,et al.Differential impact of weight loss and glycemic control on inflammasome signaling[J].Obesity,2020,28(3):609-615.
24、 MAEDLER K,SERGEEV P,RIS F,et al.Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets[J].J Clin Iinves,2002,110(6):851-860. MAEDLER K,SERGEEV P,RIS F,et al.Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets[J].J Clin Iinves,2002,110(6):851-860.
25、 RODRIGUES E-LACERDA R,FANG H,ROBIN N,et al.Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes[J].Biomed J,2023,46(5):100610. RODRIGUES E-LACERDA R,FANG H,ROBIN N,et al.Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes[J].Biomed J,2023,46(5):100610.
26、 CHAWLA A,NGUYEN K D,GOH Y P.Macrophage-mediated inflammation in metabolic disease[J].Nat Rev Immunol,2011,11(11):738-749. CHAWLA A,NGUYEN K D,GOH Y P.Macrophage-mediated inflammation in metabolic disease[J].Nat Rev Immunol,2011,11(11):738-749.
27、 BOUTENS L,STIENSTRA R.Adipose tissue macrophages:Going off track during obesity[J].Diabetologia,2016,59(5):879-894. BOUTENS L,STIENSTRA R.Adipose tissue macrophages:Going off track during obesity[J].Diabetologia,2016,59(5):879-894.
28、 CIECKO A E,FODA B,BARR J Y,et al.Interleukin-27 is essential for type 1 diabetes development and sj?gren syndrome-like inflammation[J].Cell Rep,2019,29(10):3073-3086.e5. CIECKO A E,FODA B,BARR J Y,et al.Interleukin-27 is essential for type 1 diabetes development and sj?gren syndrome-like inflammation[J].Cell Rep,2019,29(10):3073-3086.e5.
29、 WANG R,HAN G,WANG J,et al.The pathogenic role of interleukin-27 in autoimmune diabetes[J].Cell Mol Life Sci,2008,65(23):3851-3860. WANG R,HAN G,WANG J,et al.The pathogenic role of interleukin-27 in autoimmune diabetes[J].Cell Mol Life Sci,2008,65(23):3851-3860.
30、 YOSHIDA H,HUNTER C A.The immunobiology of interleukin-27[J].Annu Rev Immunol,2015(33):417-443. YOSHIDA H,HUNTER C A.The immunobiology of interleukin-27[J].Annu Rev Immunol,2015(33):417-443.
31、 LIPS M A,van KLINKEN J B,PIJL H,et al.Weight loss induced by very low calorie diet is associated with a more beneficial systemic inflammatory profile than by Roux-en-Y gastric bypass[J].Metabolism,2016,65(11):1614-1620. LIPS M A,van KLINKEN J B,PIJL H,et al.Weight loss induced by very low calorie diet is associated with a more beneficial systemic inflammatory profile than by Roux-en-Y gastric bypass[J].Metabolism,2016,65(11):1614-1620.
32、 KATSOGIANNOS P,KAMBLE P G,PEREIRA M J,et al.Changes in circulating cytokines and adipokines after RYGB in patients with and without type 2 diabetes[J].Obesity,2021,29(3):535-542. KATSOGIANNOS P,KAMBLE P G,PEREIRA M J,et al.Changes in circulating cytokines and adipokines after RYGB in patients with and without type 2 diabetes[J].Obesity,2021,29(3):535-542.
33、 VILLARREAL-CALDERON J R,CUELLAR-TAMEZ R,CASTILLO E C,et al.Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery[J].Sci Rep,2021,11(1):12127. VILLARREAL-CALDERON J R,CUELLAR-TAMEZ R,CASTILLO E C,et al.Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery[J].Sci Rep,2021,11(1):12127.
34、 TURKOGLU F,GULER M,ERDEM H,et al.Effect of bariatric surgery procedures on serum cytokine and Nesfatin-1 levels[J].Surgeon,2023,21(5):e287-e291. TURKOGLU F,GULER M,ERDEM H,et al.Effect of bariatric surgery procedures on serum cytokine and Nesfatin-1 levels[J].Surgeon,2023,21(5):e287-e291.
35、 SALMAN M A,ABDALLAH A,MIKHAIL H M S,et al.Long-term impact of mini-gastric bypass on inflammatory cytokines in cohort of morbidly obese patients:A prospective study[J].Obes Surg,2020,30(6):2338-2344. SALMAN M A,ABDALLAH A,MIKHAIL H M S,et al.Long-term impact of mini-gastric bypass on inflammatory cytokines in cohort of morbidly obese patients:A prospective study[J].Obes Surg,2020,30(6):2338-2344.
36、 ROSSI I,OMOTOSHO P,POIRIER J,et al.Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics[J].Surgery,2021,169(3):539-542. ROSSI I,OMOTOSHO P,POIRIER J,et al.Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics[J].Surgery,2021,169(3):539-542.
37、 LINDEGAARD K K,JORGENSEN N B,JUST R,et al.Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes[J].Diabetol Metab Syndr,2015(7):12. LINDEGAARD K K,JORGENSEN N B,JUST R,et al.Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes[J].Diabetol Metab Syndr,2015(7):12.
38、 de BAAT A,TRINH B,ELLINGSGAARD H,et al.Physiological role of cytokines in the regulation of mammalian metabolism[J].Trends Immunol,2023,44(8):613-627. de BAAT A,TRINH B,ELLINGSGAARD H,et al.Physiological role of cytokines in the regulation of mammalian metabolism[J].Trends Immunol,2023,44(8):613-627.
39、 MONDANELLI G,ALBINI E,ORECCHINI E,et al.Pathogenetic interplay between IL-6 and tryptophan metabolism in an experimental model of obesity[J].Front Immunol,2021(12):713989. MONDANELLI G,ALBINI E,ORECCHINI E,et al.Pathogenetic interplay between IL-6 and tryptophan metabolism in an experimental model of obesity[J].Front Immunol,2021(12):713989.
40、 GNACI?SKA M,MA?GORZEWICZ S,GUZEK M,et al.Adipose tissue activity in relation to overweight or obesity[J].Endokrynol Pol,2010,61(2):160-168. GNACI?SKA M,MA?GORZEWICZ S,GUZEK M,et al.Adipose tissue activity in relation to overweight or obesity[J].Endokrynol Pol,2010,61(2):160-168.
41、 BASTARD J P,JARDEL C,BRUCKERT E,et al.Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss[J].J Clin Endocrino Metab,2000,85(9):3338-3342. BASTARD J P,JARDEL C,BRUCKERT E,et al.Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss[J].J Clin Endocrino Metab,2000,85(9):3338-3342.
42、 KOC G,DORAN T,UYGUR M M,et al.Obesity is associated with IL-6 gene polymorphisms rs1800795 and rs1800796 but not SOCS3 rs4969170[J].Mol Biol Rep,2023,50(3):2041-2048. KOC G,DORAN T,UYGUR M M,et al.Obesity is associated with IL-6 gene polymorphisms rs1800795 and rs1800796 but not SOCS3 rs4969170[J].Mol Biol Rep,2023,50(3):2041-2048.
43、 SALMAN M A,SALMAN A A,NAFEA M A,et al.Study of changes of obesity-related inflammatory cytokines after laparoscopic sleeve gastrectomy[J].ANZ J Surg,2019,89(10):1265-1269. SALMAN M A,SALMAN A A,NAFEA M A,et al.Study of changes of obesity-related inflammatory cytokines after laparoscopic sleeve gastrectomy[J].ANZ J Surg,2019,89(10):1265-1269.
44、 LIU R,NIKOLAJCZYK B S.Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond[J].Front Immunol,2019(10):1587. LIU R,NIKOLAJCZYK B S.Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond[J].Front Immunol,2019(10):1587.
45、 ZATTERALE F,LONGO M,NADERI J,et al.Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J].Front Physiol,2020(10):1607. ZATTERALE F,LONGO M,NADERI J,et al.Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J].Front Physiol,2020(10):1607.
46、 WANG Q,LI D,CAO G,et al.IL-27 signalling promotes adipocyte thermogenesis and energy expenditure[J].Nature,2021,600(7888):314-318. WANG Q,LI D,CAO G,et al.IL-27 signalling promotes adipocyte thermogenesis and energy expenditure[J].Nature,2021,600(7888):314-318.
47、 KOCHUMON S,A L MADHOUN A,AL-RASHED F,et al.Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance[J].Sci Rep,2020,10(1):16364. KOCHUMON S,A L MADHOUN A,AL-RASHED F,et al.Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance[J].Sci Rep,2020,10(1):16364.
48、 KUNZ H E,HART C R,GRIES K J,et al.Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity[J].Am J Physiol Endocrinol Metab,2021,321(1):E105-E121. KUNZ H E,HART C R,GRIES K J,et al.Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity[J].Am J Physiol Endocrinol Metab,2021,321(1):E105-E121.
49、 ZHU X,TU Y,CHEN H,et al.Micro-environment and intracellular metabolism modulation of adipose tissue macrophage polarization in relation to chronic inflammatory diseases[J].Diabetes Metab Res Rev,2018,34(5):e2993. ZHU X,TU Y,CHEN H,et al.Micro-environment and intracellular metabolism modulation of adipose tissue macrophage polarization in relation to chronic inflammatory diseases[J].Diabetes Metab Res Rev,2018,34(5):e2993.
50、 NAWAZ A,AMINUDDIN A,KADO T,et al.CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors[J].Nat Commun,2017,8(1):286. NAWAZ A,AMINUDDIN A,KADO T,et al.CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors[J].Nat Commun,2017,8(1):286.
51、 KHANNA D,KHANNA S,KHANNA P,et al.Obesity:A chronic low-grade inflammation and its markers[J].Cureus,2022,14(2):e22711. KHANNA D,KHANNA S,KHANNA P,et al.Obesity:A chronic low-grade inflammation and its markers[J].Cureus,2022,14(2):e22711.
52、 WEISBERG S P,MCCANN D,DESAI M,et al.Obesity is associated with macrophage accumulation in adipose tissue[J].J Clin Invest,2003,112(12):1796-1808. WEISBERG S P,MCCANN D,DESAI M,et al.Obesity is associated with macrophage accumulation in adipose tissue[J].J Clin Invest,2003,112(12):1796-1808.
53、 KAWAI T,AUTIERI M V,SCALIA R.Adipose tissue inflammation and metabolic dysfunction in obesity[J].Am J Physiol Cell Physiol,2021,320(3):C375-c391. KAWAI T,AUTIERI M V,SCALIA R.Adipose tissue inflammation and metabolic dysfunction in obesity[J].Am J Physiol Cell Physiol,2021,320(3):C375-c391.
54、 BOUMELHEM B B,ASSINDER S J,BELL-ANDERSON K S,et al.Flow cytometric single cell analysis reveals heterogeneity between adipose depots[J].Adipocyte,2017,6(2):112-123. BOUMELHEM B B,ASSINDER S J,BELL-ANDERSON K S,et al.Flow cytometric single cell analysis reveals heterogeneity between adipose depots[J].Adipocyte,2017,6(2):112-123.
55、 ZATTERALE F,LONGO M,NADERI J,et al.Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J].Front Physiol,2019(10):1607. ZATTERALE F,LONGO M,NADERI J,et al.Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J].Front Physiol,2019(10):1607.
56、 LI C,XU M M,WANG K,et al.Macrophage polarization and meta-inflammation[J].Transl Res,2018(191):29-44. LI C,XU M M,WANG K,et al.Macrophage polarization and meta-inflammation[J].Transl Res,2018(191):29-44.
57、 HARMON D B,SRIKAKULAPU P,KAPLAN J L,et al.Protective role for B-1b B cells and IgM in obesity-associated inflammation,glucose intolerance,and insulin resistance[J].Arterioscler Thromb Vasc Biol,2016,36(4):682-691. HARMON D B,SRIKAKULAPU P,KAPLAN J L,et al.Protective role for B-1b B cells and IgM in obesity-associated inflammation,glucose intolerance,and insulin resistance[J].Arterioscler Thromb Vasc Biol,2016,36(4):682-691.
58、 LEE Y S,WOLLAM J,OLEFSKY J M.An integrated view of immunometabolism[J].Cell,2018,172(1):22-40. LEE Y S,WOLLAM J,OLEFSKY J M.An integrated view of immunometabolism[J].Cell,2018,172(1):22-40.
59、 KANE H,LYNCH L.Innate immune control of adipose tissue homeostasis[J].Trends Immuno,2019,40(9):857-872. KANE H,LYNCH L.Innate immune control of adipose tissue homeostasis[J].Trends Immuno,2019,40(9):857-872.
60、 REMMERIE A,MARTENS L,SCOTT C L.Macrophage subsets in obesity,aligning the liver and adipose tissue[J].Front Endocrinol,2020(11):259. REMMERIE A,MARTENS L,SCOTT C L.Macrophage subsets in obesity,aligning the liver and adipose tissue[J].Front Endocrinol,2020(11):259.
61、 HEINONEN S,JOKINEN R,RISSANEN A,et al.White adipose tissue mitochondrial metabolism in health and in obesity[J].Obes Rev,2020,21(2):e12958. HEINONEN S,JOKINEN R,RISSANEN A,et al.White adipose tissue mitochondrial metabolism in health and in obesity[J].Obes Rev,2020,21(2):e12958.
62、 SCHEELE C,WOLFRUM C.Brown adipose crosstalk in tissue plasticity and human metabolism[J].Endocr Rev,2020,41(1):53-65. SCHEELE C,WOLFRUM C.Brown adipose crosstalk in tissue plasticity and human metabolism[J].Endocr Rev,2020,41(1):53-65.
63、 GUSTAFSON B,SMITH U.Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes[J].J Biol Chem,2006,281(14):9507-9516. GUSTAFSON B,SMITH U.Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes[J].J Biol Chem,2006,281(14):9507-9516.
64、 LAWLER H M,UNDERKOFLER C M,KERN P A,et al.Adipose tissue hypoxia,inflammation,and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects[J].J Clin Endocrinol Metab,2016,101(4):1422-1428. LAWLER H M,UNDERKOFLER C M,KERN P A,et al.Adipose tissue hypoxia,inflammation,and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects[J].J Clin Endocrinol Metab,2016,101(4):1422-1428.
65、 GURIA S,HOORY A,DAS S,et al.Adipose tissue macrophages and their role in obesity-associated insulin resistance:An overview of the complex dynamics at play[J].Biosci Rep,2023,43(3):BSR20220200. GURIA S,HOORY A,DAS S,et al.Adipose tissue macrophages and their role in obesity-associated insulin resistance:An overview of the complex dynamics at play[J].Biosci Rep,2023,43(3):BSR20220200.
66、 WATANABE Y,NAGAI Y,TAKATSU K.Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance[J].Nutrients,2013,5(9):3757-3778. WATANABE Y,NAGAI Y,TAKATSU K.Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance[J].Nutrients,2013,5(9):3757-3778.
67、 REHMAN K,AKASH M S H,LIAQAT A,et al.Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus[J].Crit Rev Eukaryot Gene Expr,2017,27(3):229-236. REHMAN K,AKASH M S H,LIAQAT A,et al.Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus[J].Crit Rev Eukaryot Gene Expr,2017,27(3):229-236.
68、 HIRANO T.IL-6 in inflammation,autoimmunity and cancer[J].Int Immunol,2021,33(3):127-148. HIRANO T.IL-6 in inflammation,autoimmunity and cancer[J].Int Immunol,2021,33(3):127-148.
69、 AKBARI M,HASSAN-ZADEH V.IL-6 signalling pathways and the development of type 2 diabetes[J].Inflammopharmacology,2018,26(3):685-698. AKBARI M,HASSAN-ZADEH V.IL-6 signalling pathways and the development of type 2 diabetes[J].Inflammopharmacology,2018,26(3):685-698.
70、 AKASH M S H,REHMAN K,LIAQAT A.Tumor necrosis factor-alpha:Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J].J Cell Biochem,2018,119(1):105-110. AKASH M S H,REHMAN K,LIAQAT A.Tumor necrosis factor-alpha:Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J].J Cell Biochem,2018,119(1):105-110.
71、 QING Z,XIAO-HUI W,XI-MEI W,et al.Vitamin C deficiency aggravates tumor necrosis factor α-induced insulin resistance[J].Eur J Pharmacol,2018(829):1-11. QING Z,XIAO-HUI W,XI-MEI W,et al.Vitamin C deficiency aggravates tumor necrosis factor α-induced insulin resistance[J].Eur J Pharmacol,2018(829):1-11.
72、 SCHMITZ J,EVERS N,AWAZAWA M,et al.Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss[J].Mol Metab,2016,5(5):328-339. SCHMITZ J,EVERS N,AWAZAWA M,et al.Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss[J].Mol Metab,2016,5(5):328-339.
73、 LEE Y S,OLEFSKY J.Chronic tissue inflammation and metabolic disease[J].Genes Dev,2021,35(5-6):307-328. LEE Y S,OLEFSKY J.Chronic tissue inflammation and metabolic disease[J].Genes Dev,2021,35(5-6):307-328.
74、 王莹. 2型糖尿病患者发生慢性肾脏病的危险因素及与肥胖的相关性研究[J].广州医药,2023,54(11):105-110. 王莹. 2型糖尿病患者发生慢性肾脏病的危险因素及与肥胖的相关性研究[J].广州医药,2023,54(11):105-110.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录